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Head and neck squamous carcinoma, including the oral
cavity, is the sixth most common cancer worldwide with
approximately 270,000 new oral cavity tumours per year.
Unfortunately, the majority of these tumours present in
late stage with the attended functional, psychological and
economic costs on their victims. It's clearly evident that
screening and early detection of the cancer and its early
precursors have the potential to reduce the morbidity and
mortality of this disease. In that context, current oral
examination methods including incandescent light or
toluidine blue, reflectance visualization and illumination
with chemiluminescent light source, are largely subjec-
tive, dependent on the experience of the examiner and are
considered in-effective tools in primary care settings.
Autofluorescence imaging has recently been shown to
improve the detection of premalignant and malignant
oral lesions. This method is based on the illumination in
the absorption of tissue fluorophore molecules (NADH
and FAD in the epithelial layer and collagen, and elastin
in the stroma) in ultraviolet visible spectrum leading to
the emission of lower energy photon that can be detected
as fluorescence from the oral surface mucosa. Studies of
these methods in normal oral mucosa have shown
increased green fluorescence in comparison to neoplastic
lesions upon ultraviolet (UV) or near UV light source. The
histopathologic manifestations and heterogeneity of oral
squamous lesions and the confounding factors for the val-
idation and the clinical applications of autofluoresence
imaging will be presented and discussed.
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